| Kent P Jones, MD | |
|
6811 Austin Center Blvd # 300, Austin, TX 78731-3166 | |
| (512) 346-8888 | |
| (512) 344-0340 |
| Full Name | Kent P Jones |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 35 Years |
| Location | 6811 Austin Center Blvd # 300, Austin, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124034491 | NPI | - | NPPES |
| 040539101 | Medicaid | TX | |
| 040539102 | Medicaid | TX | |
| 040539103 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | K6026 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Austin Regional Clinic Pa | 3072507789 | 349 |
News Archive
Precision for Medicine announced today that its subsidiary, Precision Bioservices, Inc., has been awarded a 7-year contract of up to $28 million to provide management and oversight of disease-study specimens for the National Institute of Allergy and Infectious Diseases.
Statins have been linked with muscle pain and other musculoskeletal adverse events in some patients. A new Pharmacology Research & Perspectives study has examined the timing of MAEs that develop during statin therapy and determined whether concomitant drugs used concurrently with statin therapy shifts the timing of MAEs.
A revolutionary new technology has been applied to reveal the inner workings of individual cancer cells - potentially identifying more effective treatment combinations for people with cancer.
A study in Cell reports the discovery of a gene that drives anthrax bacteria's toxic effects. The gene could offer a potential new target for countermeasures against the lethal toxin, according to the researchers.
LifePoint Hospitals, Inc. today announced results for the first quarter ended March 31, 2011.
› Verified 3 days ago
| Entity Name | Austin Regional Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821157579 PECOS PAC ID: 3072507789 Enrollment ID: O20040414000198 |
News Archive
Precision for Medicine announced today that its subsidiary, Precision Bioservices, Inc., has been awarded a 7-year contract of up to $28 million to provide management and oversight of disease-study specimens for the National Institute of Allergy and Infectious Diseases.
Statins have been linked with muscle pain and other musculoskeletal adverse events in some patients. A new Pharmacology Research & Perspectives study has examined the timing of MAEs that develop during statin therapy and determined whether concomitant drugs used concurrently with statin therapy shifts the timing of MAEs.
A revolutionary new technology has been applied to reveal the inner workings of individual cancer cells - potentially identifying more effective treatment combinations for people with cancer.
A study in Cell reports the discovery of a gene that drives anthrax bacteria's toxic effects. The gene could offer a potential new target for countermeasures against the lethal toxin, according to the researchers.
LifePoint Hospitals, Inc. today announced results for the first quarter ended March 31, 2011.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kent P Jones, MD 6210 E Hwy 290, Austin, TX 78723-1142 Ph: (512) 407-8686 | Kent P Jones, MD 6811 Austin Center Blvd # 300, Austin, TX 78731-3166 Ph: (512) 346-8888 |
News Archive
Precision for Medicine announced today that its subsidiary, Precision Bioservices, Inc., has been awarded a 7-year contract of up to $28 million to provide management and oversight of disease-study specimens for the National Institute of Allergy and Infectious Diseases.
Statins have been linked with muscle pain and other musculoskeletal adverse events in some patients. A new Pharmacology Research & Perspectives study has examined the timing of MAEs that develop during statin therapy and determined whether concomitant drugs used concurrently with statin therapy shifts the timing of MAEs.
A revolutionary new technology has been applied to reveal the inner workings of individual cancer cells - potentially identifying more effective treatment combinations for people with cancer.
A study in Cell reports the discovery of a gene that drives anthrax bacteria's toxic effects. The gene could offer a potential new target for countermeasures against the lethal toxin, according to the researchers.
LifePoint Hospitals, Inc. today announced results for the first quarter ended March 31, 2011.
› Verified 3 days ago
Robert A. Williamson Jr., M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6811 Austin Center Blvd, Suite 300, Austin, TX 78731 Phone: 512-346-8888 Fax: 512-406-7321 | |
Dr. Jeffrey S Zapalac, M.D., F.A.C.S. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3705 Medical Pkwy, Suite 310, Austin, TX 78705 Phone: 512-458-6391 Fax: 512-390-4091 | |
Dr. Joel William Jones, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 9835 N Lake Creek Pkwy, Austin, TX 78717 Phone: 832-822-0629 | |
Dr. Tibor Ruff, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 40 N Interstate 35 Apt 9d1, Austin, TX 78701 Phone: 512-947-4612 | |
James R Eskew, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4315 James Casey St, Suite 300, Austin, TX 78745 Phone: 512-444-7944 Fax: 512-444-7946 | |
David Crockett Teller, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 7901 Metropolis Dr, Austin, TX 78744 Phone: 512-823-4880 Fax: 512-823-4155 |